Opthea Announces Executive Leadership Changes and Senior Hires
Daniel Geffken appointed Chief Financial Officer ad interim Mike Campbell appointed Chief Commercial Officer Three senior leaders appointed for Biometrics, Clinical Operations and Market Access
| Ticker |
Sentiment |
Impact |
|
OPT
|
Neutral
|
28 %
|
|
PTAIF
|
Neutral
|
2 %
|
|
MRES
|
Neutral
|
2 %
|
|
VTRS
|
Neutral
|
2 %
|
|
GLP
|
Neutral
|
2 %
|
|
ABBV
|
Neutral
|
2 %
|
|
GILD
|
Neutral
|
2 %
|
|
MRNS
|
Neutral
|
2 %
|
